Showing 17,741 - 17,760 results of 29,346 for search '(( 50 ((((teer decrease) OR (a decrease))) OR (nn decrease)) ) OR ( a web decrease ))', query time: 0.72s Refine Results
  1. 17741

    DNA damage evoked by <i>K. pneumoniae</i> 1084 infection <i>in vivo</i>. by Yi-Chyi Lai (213766)

    Published 2014
    “…An asterisk (*) represents a significant decrease in the Δ<i>clbA</i>-infected group in comparison with the <i>K. pneumoniae</i> 1084-infected group by the Mann-Whitney U test (two-tailed; <i>P</i><0.05). …”
  2. 17742

    PathogenFinder - Distinguishing Friend from Foe Using Bacterial Whole Genome Sequence Data by Salvatore Cosentino (477248)

    Published 2013
    “…We describe <i>PathogenFinder</i> (<a href="http://cge.cbs.dtu.dk/services/PathogenFinder/" target="_blank">http://cge.cbs.dtu.dk/services/PathogenFinder/</a>), a web-server for the prediction of bacterial pathogenicity by analysing the input proteome, genome, or raw reads provided by the user. …”
  3. 17743
  4. 17744
  5. 17745

    Standardized mean effect differences between wet-lab experiment and model simulations. by Rachael Miller Neilan (10678614)

    Published 2021
    “…Positive Hedges’ <i>g</i> is indicative of an increase in pain-like effect for the indicated comparison and a negative Hedges’ <i>g</i> is indicative of a decrease in pain-like effects. …”
  6. 17746
  7. 17747

    BPLF1 selectively inhibits the detection of TOP2-induced DNA damage. by Jinlin Li (2267896)

    Published 2021
    “…The expression of catalytically active BPLF1 was associated with a significant decrease of Etoposide induced nuclear γH2AX fluorescence and decreased formation of 53BP1 foci. …”
  8. 17748
  9. 17749
  10. 17750
  11. 17751
  12. 17752
  13. 17753

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  14. 17754
  15. 17755

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
  16. 17756
  17. 17757
  18. 17758
  19. 17759
  20. 17760